Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
       4211  Chlorethylamines
       4212  Ethyleneimines
       4213  Sulfonate esters
       4219  Others
         D00369  Melphalan (JP17/USP/INN)
         D07085  Bendamustine hydrochloride (JAN/USAN)
         D00254  Carmustine (JAN/USP/INN)
         D05932  Streptozocin (JAN/USAN/INN)
         D01059  Nimustine hydrochloride (JAN)
         D01760  Ranimustine (JAN/INN)
         D06067  Temozolomide (JAN/USAN/INN)
         D00288  Dacarbazine (JAN/USP/INN)
         D06397  Estramustine phosphate sodium hydrate (JAN)
L01AA03
L01AA09
L01AD01
L01AD04
L01AD06
L01AD07
L01AX03
L01AX04
L01XX11
     422  Antimetabolites
     423  Antibiotics
     424  Plant extract preparations
     429  Miscellaneous
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 7, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version